StockData
C21 Investments Inc. logo

C21 Investments Inc. (CWLXF) stock

CWLXFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 12, 2026Score 6/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

C21 Investments Inc. grew revenue 15.3% to $32.61M over fiscal 2026. Operating income rose 54.8% to $2.28M, moving the operating margin from 5.2% to 7.0%. Free cash flow was $1.12M, down 59.2% from a year earlier.

Revenue
$32.61M
+15.3% vs. a year earlier
Operating income
$2.28M
+54.8% vs. a year earlier
Free cash flow
$1.12M
-59.2% vs. a year earlier
EPS, diluted
-$0.03
FY2026

Key statistics

Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$32.61M
Net income
-$3.24M
EPS, diluted
-$0.03
Free cash flow
$1.12M

Valuation needs the share price. It fills in once daily prices are connected.

Nine years at a glance

Fiscal years 2017 to 2026, USD

Revenue

$32.61M+15.3% YoY

Gross profit

$13.61M+22.0% YoY

Operating income

$2.28M+54.8% YoY

Net income

-$3.24M

EPS, diluted

-$0.03

Free cash flow

$1.12M-59.2% YoY
Reported period

Press releases

Releases C21 Investments filed with the SEC as exhibits to Form 8-K or 6-K

  1. Interim Condensed Consolidated Financial Statements
    6-K
  2. For the three months ended June 30, 2026
    6-K
  3. I, Sonny Newman, Chief Executive Officer of C21 Investments Inc. , certify the following:
    6-K
  4. C21 Shareholders Approve Arrangement with Vireo Growth Inc.
    6-K
  5. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
    6-K
  6. 19th Floor, 885 West Georgia Street
    6-K
All press releases and earnings

About C21 Investments

Medicinal Chemicals & Botanical Products

C21 Investments Inc. is a vertically integrated cannabis enterprise that cultivates, processes, distributes, and retails cannabis and hemp-derived consumer packaged goods. Its operations span cultivation, extraction processing, and retail dispensing. The company produces in-house consumer products, including flower, pre-rolls, cartridges, and concentrates sold under brands such as Silver State Relief, Phantom Farms, and Hood Oil. These items, along with third-party branded products, are distributed through company-owned retail dispensaries and wholesale channels. Its customer base includes both recreational adult-use consumers and medical cannabis patients, as well as wholesale buyers in the cannabis market.

Company profile, executives and history

C21 Investments stock: common questions

What is CWLXF's P/E ratio?

C21 Investments lost money over fiscal 2026 (diluted EPS -$0.03), so it has no meaningful P/E ratio.

How much revenue does C21 Investments make?

C21 Investments reported revenue of $32.61M for fiscal 2026, up 15.3% from a year earlier.

Does C21 Investments pay a dividend?

No. C21 Investments has not paid a cash dividend over the last twelve months.

Who are C21 Investments's competitors?

Companies most similar to C21 Investments by business, industry and size include LEEEF, IMCC, GLAS, JUSH, CGC.

See a number that looks wrong?